Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Jingdong CJ Pharmaceutical is a joint venture between JD Health and the South Korean conglomerate CJ Group, specifically focused on pharmaceutical supply chain and distribution. Established in 2020 and headquartered in Zhengzhou, Henan, the company leverages JD's logistics infrastructure and digital health platform alongside CJ's pharmaceutical industry expertise. Its primary operations involve the wholesale and retail of western medicines, traditional Chinese medicines, and medical devices. The company aims to streamline the pharmaceutical circulation process in China through integrated digital solutions and efficient warehousing. It serves as a key regional player in JD Health's broader strategy to expand its offline pharmaceutical footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Jingdong Xijian Pharmaceutical.